<DOC>
	<DOCNO>NCT02800863</DOCNO>
	<brief_summary>The purpose prospective , multicenter , single arm post-approval study demonstrate continue safety Axium Neurostimulator System dorsal root ganglion ( DRG ) stimulation . The primary endpoint 12-month serious adverse event rate permanent implant .</brief_summary>
	<brief_title>TARGET Post-Approval Study</brief_title>
	<detailed_description>A maximum 376 adult subject moderate severe chronic , intractable , pain low limb due CRPS type I II undergo trial Axium Neurostimulator System across 40 study site United States . Only subject report 50 % great reduction overall pain intensity direct patient-reported percentage pain relief receive permanent implant . Subjects return office follow-up 1 , 3 , 6 12 month post-permanent implant .</detailed_description>
	<mesh_term>Complex Regional Pain Syndromes</mesh_term>
	<mesh_term>Reflex Sympathetic Dystrophy</mesh_term>
	<criteria>Subject male female 22 75 year age . Subject moderate severe chronic intractable pain lower limbs result Complex Regional Pain Syndrome ( CRPS ) type I II . Subject baseline VAS score &gt; 60 mm overall pain time baseline assessment . Subject willing able comply study requirement . Subject able provide write informed consent . Subject active implantable medical device include limited cardiac pacemaker cardiac defibrillator . Subject currently involve medically related litigation , include worker compensation . Subject previously fail ( i.e . receive &gt; 50 % pain relief ) spinal cord stimulation . Subject life expectancy le one year . Subject pregnant child bear potential use adequate contraception determine investigator . Subject , plan , spinal cord stimulation system infusion pump system implant . Subject , plan , peripheral nerve stimulation system ( PNS ) peripheral nerve field stimulation system ( PNfS ) implant . Subject consider poor surgical study candidate , may include , limited following : medical , social , psychological problem could complicate implant procedure and/or recovery implant procedure could complicate require procedure evaluation study judgment investigator .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>